- Home
- ISPO vs ACRV Comparison
ISPO vs ACRV Comparison
Compare ISPO & ACRV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ISPO
- ACRV
- Stock Information
- Founded
- ISPO 2010
- ACRV 2018
- Country
- ISPO United States
- ACRV United States
- Employees
- ISPO N/A
- ACRV N/A
- Industry
- ISPO Blank Checks
- ACRV Medicinal Chemicals and Botanical Products
- Sector
- ISPO Finance
- ACRV Health Care
- Exchange
- ISPO Nasdaq
- ACRV Nasdaq
- Market Cap
- ISPO 44.3M
- ACRV 41.7M
- IPO Year
- ISPO N/A
- ACRV 2022
- Fundamental
- Price
- ISPO $3.06
- ACRV $1.33
- Analyst Decision
- ISPO
- ACRV Buy
- Analyst Count
- ISPO 0
- ACRV 7
- Target Price
- ISPO N/A
- ACRV $17.40
- AVG Volume (30 Days)
- ISPO 30.2K
- ACRV 185.7K
- Earning Date
- ISPO 08-12-2025
- ACRV 08-13-2025
- Dividend Yield
- ISPO N/A
- ACRV N/A
- EPS Growth
- ISPO N/A
- ACRV N/A
- EPS
- ISPO N/A
- ACRV N/A
- Revenue
- ISPO $261,225,000.00
- ACRV N/A
- Revenue This Year
- ISPO N/A
- ACRV N/A
- Revenue Next Year
- ISPO $148.66
- ACRV $805.34
- P/E Ratio
- ISPO N/A
- ACRV N/A
- Revenue Growth
- ISPO N/A
- ACRV N/A
- 52 Week Low
- ISPO $2.19
- ACRV $1.05
- 52 Week High
- ISPO $7.17
- ACRV $10.16
- Technical
- Relative Strength Index (RSI)
- ISPO 51.97
- ACRV 50.66
- Support Level
- ISPO $2.85
- ACRV $1.30
- Resistance Level
- ISPO $3.18
- ACRV $1.42
- Average True Range (ATR)
- ISPO 0.22
- ACRV 0.08
- MACD
- ISPO 0.03
- ACRV 0.00
- Stochastic Oscillator
- ISPO 65.67
- ACRV 55.32
About ISPO Inspirato Incorporated
Inspirato Inc is a private, luxury hospitality club that provides its members with access to an exclusive portfolio of high-end vacation homes, luxury hotels, and curated travel experiences worldwide. The club offers personalized service, dedicated trip planning, and seamless access to exceptional properties through its innovative model designed to ensure the service, certainty and value that discerning customers demand. The Inspirato portfolio of curated luxury vacation options includes approximately 350 private luxury vacation homes and accommodations at over 220 luxury hotel and resort partners in over 180 destinations around the world.
About ACRV Acrivon Therapeutics Inc.
Acrivon Therapeutics Inc is a clinical-stage biopharmaceutical company developing oncology medicines that the Firm matches to patients whose tumors are predicted to be sensitive to each specific medicine by utilizing its proteomics-based patient responder identification platform. The company's pipeline includes the Phase 2 lead program, ACR-368, referred to as prexasertib, a targeted oncology asset, as well as preclinical stage pipeline programs targeting critical nodes in the DNA Damage Response and cell cycle regulation pathways, including WEE1, a protein kinase, and PKMYT1, a closely related protein serine/threonine kinase.